Impact of volume status on blood pressure and left ventricle structure in patients undergoing chronic hemodialysis

Renal Failure

Volumn 33, Issue 4, 2011, Pages 377-381

  Koc, Yener ^a   Unsal, Abdulkadir ^a   Kayabasi, Hasan ^b   Oztekin, Erkan ^a   Sakaci, Tamer ^a   Ahbap, Elbis ^a   Yilmaz, Murvet ^a   Akgun, Ali Oguz ^a  

^a Sisli Etfal Research and Educational Hospital   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

ABPM; blood pressure; Hemodialysis; hypervolemia; left ventricular hypertrophy

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CHEMICAL ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VALVE; HEMATOLOGY; HEMODIALYSIS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; PATIENT CODING; PREDICTOR VARIABLE; PRIORITY JOURNAL; ULTRAFILTRATION; UREA BLOOD LEVEL; WEIGHT GAIN;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD VOLUME; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; YOUNG ADULT;

EID: 79955604198     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.565139     Document Type: Article

References (45)

1. Hull A, Long D, Pettinger WA, Parker TF, III. The control of hypertension in patients undergoing regular maintenance hemodialysis. Kidney Int. 1974;7(Suppl. 2):187-194.
2. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Associa-tion of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270-3277. (Pubitemid 37509303)
3. Salem MM. Hypertension in the hemodialysis population: A survey of 649 patients. Am J Kidney Dis. 1995;26:461-468.
4. Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW. Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects. Am J Kidney Dis. 2004;44:16-21.
5. Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM. Sodium balance in renal failure: A comparison of patients with normal subjects under extremes of sodium intake. Hypertension. 1985;7:714-721. (Pubitemid 15238769)
6. Kooman JP, Van Der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients: Reflections on pathophysiological mechanisms. Blood Purif. 2004;22:55-59. (Pubitemid 38142289)
7. Zoccali C, Benedetto FA, Tripepi G, Mallamaci F. Cardiac consequences of hypertension in hemodialysis patients. Semin Dial. 2004;17:299-303. (Pubitemid 39107654)
8. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol. 1994;4:1486-1490.
9. Cuspidi C, Ciulla M, Zanchetti A. Hypertensive myocardial fibrosis. Nephrol Dial Transplant. 2006;21:20-23. (Pubitemid 43057102)
10. Stewart GA, Gansevoort RT, Mark PB, et al. Electrocardio-graphic abnormalities and uremic cardiomyopathy. Kidney Int. 2005;67:217-226.
11. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12:1079-1084 (Pubitemid 32378350)
12. K/DOQI. K/DOQI clinical practice guidelines for cardiovas-cular disease in dialysis patients. Am J Kidney Dis. 2005;45(Suppl. 3):16-153.
13. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618. (Pubitemid 8066109)
14. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222-1230. (Pubitemid 15184198)
15. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocar-diographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186-192.
16. Tucker B, Fabbian F, Giles M, et al. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant. 1997;12:724-728. (Pubitemid 27170427)
17. Erturk S, Ertug AE, Ates K, et al. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in hemodialysis patients. Nephrol Dial Transplant. 1996;11:2050-2054. (Pubitemid 26345472)
18. Foley R, Herzog C, Collins A. Blood pressure and long-term mortality in United States hemodialysis patients: ESRD waves 3 and 4 study. Kidney Int. 2002;62:1784-1790. (Pubitemid 35286287)
19. Mendes R, Santos S, Dorigo D, et al. The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in hemodialysis patients. Blood Pres Monit. 2003;8:243-248. (Pubitemid 39089946)
20. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801. (Pubitemid 24363980)
21. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 2005;46:156-161. (Pubitemid 40946507)
22. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407-2415. (Pubitemid 36682819)
23. Peixoto A, Santos S, Mendes R, et al. Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis. 2000;36:983-990.
24. Nystrom F, Malmqvist K, Ohman KP, Kahan T. Nurse recorded and ambulatory blood pressure predicts treatment induced reduction of left ventricular hypertrophy equally well in hypertension: Results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study. J Hypertens. 2002;20:1527-1533. (Pubitemid 34921176)
25. Zoccali C, Mallamaci F, Tripepi G, et al. Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambula-tory BP monitoring in hemodialysis patients: CREED investi-gators. J Hypertens. 1999;17:1751-1758.
26. Cannella G, Paoletti E, Ravera G, et al. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hyper-trophy in uremic dialysis patients. Kidney Int. 2000;58:260-268. (Pubitemid 30429871)
27. Amar J, Vernier I, Rossignol E, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485-2491. (Pubitemid 30340746)
28. Tripepi G, Fagugli RM, Dattolo P, et al. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialy-sis patients. Kidney Int. 2005;68:1294-1302. (Pubitemid 43246450)
29. Agarwal R. Assessment of blood pressure in hemodialysis patients. Semin Dial. 2002;15(5):299-304.
30. Leypoldt J, Cheung A, Delmez J, et al. Relationship between volume status and blood pressure during chronic hemodialy-sis. Kidney Int. 2002;61:266-275. (Pubitemid 34075154)
31. Khosla U, Johnson R. Hypertension in the hemodialysis patient and the "lag phenomenon": Insights into pathophysiology and clinical management. Am J Kidney Dis. 2004;43:739-751. (Pubitemid 38401891)
32. Blankestijn P. Sympathetic hyperactivity in chronic kidney disease. Nephrol Dial Transplant. 2004;19:1354-1357.
33. Luik AJ, Gladziwa U, Kooman JP, et al. Influence of interdia-lytic weight gain on blood pressure in hemodialysis patients. Blood Purif. 1994;12:259-266. (Pubitemid 24324841)
34. Luik AJ, van Kuijk WHM, Spek J, et al. Effects of hyperv-olemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis. 1997;30:466-474. (Pubitemid 27422291)
35. Rahman M, Dixit A, Donley V, et al. Factors associated with inadequate blood pressure control in hypertensive hemodialy-sis patients. Am J Kidney Dis. 1999;33:498-506.
36. Rocco MV, Yan G, Heyka RJ, et al. Risk factors for hyperten-sion in chronic hemodialysis patients: Baseline data from the HEMO Study. Am J Nephrol. 2001;21:280-288. (Pubitemid 32757311)
37. Inrig JK, Patel UD, Gillespie BS, et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis. 2007;50(1):108-118.
38. Mominadam S, Ozkahya M, Kayikcioglu M, et al. Interdia-lytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients. Hemodial Int. 2008;12:322-327.
39. Kayikcioglu M, Tumuklu M, Ozkahya M, et al. The benefit of salt restriction in the treatment of end-stage renal disease by hemodialysis. Nephrol Dial Transplant. 2009;24(3):956-962.
40. Gunal AI, Kirciman E, Guler M, Yavuzkir M, Celiker H. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients? Ren Fail. 2004;26(4): 405-409. (Pubitemid 39167618)
41. Gunal AI, Karaca I, Aygen B, Yavuzkir M, Dogukan A, Celiker H. Strict fluid volume control and left ventricular hypertrophy in hypertensive patients on chronic hemodialysis: A cross-sectional study. J Int Med Res. 2004;32(1):70-77. (Pubitemid 38159234)
42. Covic A, Goldsmith DJ, Covic M Reduced blood pressure diurnal variability as a risk factor for progressive left ventricu-lar dilatation in hemodialysis patients. Am J Kidney Dis. 2000;35:617-623. (Pubitemid 30185505)
43. Agarwal R, Peixoto AJ, Santos SF, Zoccali C Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit. 2009;14:2-11.
44. Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528-536. (Pubitemid 20055961)
45. Verdecchia P, Angeli F, Cavallini C Ambulatory blood pres-sure for cardiovascular risk stratification. Circulation. 2007;115:2091-2093. (Pubitemid 46659059)